There are currently 10 clinical trials in Panama City, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Bay Medical Center, Gulf Coast Cancer Treatment Center, GSK Investigational Site and Boehringer Ingelheim Investigational Site. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Product Surveillance Registry
NCT01524276
Recruiting
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Gender:
ALL
Ages:
All
Trial Updated:
01/21/2025
Locations: Not set, Panama City, Florida
Conditions: Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm, Mechanical Circulatory Support, Respiratory Therapy, Aortic, Peripheral Vascular and Venous Disorders, Minimally Invasive Surgical Procedures, Diagnostic Techniques and Procedures, Surgical Procedures, Operative, Renal Insufficiency, Neurovascular, Coronary Artery Disease, Ear, Nose and Throat Disorder
Register for Updates
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180
Recruiting
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Gender:
ALL
Ages:
All
Trial Updated:
12/23/2024
Locations: Not set, Panama City, Florida
Conditions: Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Register for Updates
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731
Recruiting
Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.
Gender:
ALL
Ages:
All
Trial Updated:
12/12/2024
Locations: Cardiovascular Institute of Northwest Florida, Panama City, Florida
Conditions: Ventricular Arrhythmia, Tachycardia
Register for Updates
CCT-102 or Expectant Management in Delayed Pregnancy Loss
NCT06121063
Recruiting
A Phase 3, multi-center clinical trial of a CCT-102 regimen or expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).
Gender:
FEMALE
Ages:
Between 18 years and 50 years
Trial Updated:
12/11/2024
Locations: Emerald Coast Obstetrics and Gynecology, Panama City, Florida
Conditions: Early Pregnancy Loss, Delayed Pregnancy Loss
Register for Updates
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia
NCT05852431
Recruiting
To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ≥500 to ≤2000 mg/dL) after 26 weeks of treatment.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
10/14/2024
Locations: 89bio Clinical Study Site, Panama City, Florida
Conditions: Severe Hypertriglyceridemia
Register for Updates
A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis
NCT05862272
Recruiting
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas (fibroids) or with moderate-to-severe pain associated with endometriosis.
Gender:
FEMALE
Ages:
Between 18 years and 50 years
Trial Updated:
09/24/2024
Locations: Panama City, Panama City, Florida
Conditions: Uterine Fibroids, Endometriosis
Register for Updates
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
NCT05639465
Recruiting
Racial and ethnic minority children who live in socioeconomically disadvantaged communities are disproportionately impacted by pandemic and climate-induced disasters. Although effective interventions have been designed to treat mental health related symptoms in post-disaster settings, accessible, empirically supported prevention interventions are needed to prevent the onset of mental and behavioral health issues among these children. Building on our preliminary findings, the proposed study exami... Read More
Gender:
ALL
Ages:
Between 8 years and 14 years
Trial Updated:
08/02/2024
Locations: Bay District Schools, Panama City, Florida
Conditions: Emotional Distress, Prosocial Behavior, Pandemic, COVID-19, Coping Skills, Social Support
Register for Updates
Lung EpiCheck Biomarkers Development Study
NCT06245876
Recruiting
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Gender:
All
Ages:
Between 20 years and 80 years
Trial Updated:
02/08/2024
Locations: Emerald Coast OBGYN, Panama City, Florida
Conditions: Lung Cancer
Register for Updates
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
NCT05289557
Recruiting
The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo.
Gender:
Female
Ages:
Between 12 years and 17 years
Trial Updated:
09/08/2023
Locations: Emerald Coast OB/GYN Clinical Research, Panama City, Florida
Conditions: Morning Sickness
Register for Updates
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
NCT05186298
Recruiting
The purpose of this study is to evaluate the AcrySof PanOptix Intraocular Lens (IOL) for binocular distance corrected near visual acuity (DCNVA) compared to TECNIS Synergy IOL. Presbyopia correcting diffractive intraocular implants (extended depth of focus, multifocal, and trifocal) provide cataract and refractive surgeons with an effective treatment means for allowing patients to experience increased spectacle independence post-cataract surgery.
Gender:
All
Ages:
22 years and above
Trial Updated:
01/10/2022
Locations: Eye Care Now, Panama City, Florida
Conditions: Cataract
Register for Updates